Expression of OX1R, OX2R, and GPR103 in early onset familial AD (EOFAD) and late onset non-familial AD (LOAD) patients was significantly reduced compared with healthy controls. Here, HCRTR2 is linked to early-onset autosomal dominant Alzheimer disease.